MetaADEDB 2.0 @ LMMD
Fractals
(ZGGHKIMDNBDHJB-RPQBTBOMSA-M)
Structure
SMILES
[O-]C(=O)C[C@H](C[C@H](/C=C/c1c(c2ccc(cc2)F)c2c(n1C(C)C)cccc2)O)O.[Na+]
Molecular Formula:
C24H25FNNaO4
Molecular Weight:
433.448
Log P:
3.2934
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
2
TPSA:
85.52
CAS Number(s):
93957-55-2; 155229-76-8
Synonym(s)
1.
Fractals
2.
Fractal
External Link(s)
MeSHD017709
PubChem Compound23679527
ChEBI77603
CHEMBLCHEMBL241778
KEGGdr:D00892
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1MyalgiaFAERS: 21
Canada Vigilance: 1
Canada Vigilance
US FAERS
2Alanine Aminotransferase IncreasedFAERS: 16US FAERS
3Blood creatine phosphokinase increasedFAERS: 15US FAERS
4Aspartate Aminotransferase IncreasedFAERS: 14US FAERS
5Gamma-Glutamyltransferase IncreasedFAERS: 14US FAERS
6AstheniaFAERS: 13US FAERS
7Blood alkaline phosphatase increasedFAERS: 13US FAERS
8Blood lactate dehydrogenase increasedFAERS: 9US FAERS
9RhabdomyolysisFAERS: 9US FAERS
10Cerebrovascular accidentFAERS: 8US FAERS
11MalaiseFAERS: 8US FAERS
12NauseaFAERS: 8US FAERS
13Blood creatinine increasedFAERS: 6US FAERS
14ChromaturiaFAERS: 6US FAERS
15Drug ineffectiveFAERS: 6US FAERS
16PruritusFAERS: 6US FAERS
17Abdominal PainFAERS: 5US FAERS
18Chest PainFAERS: 5US FAERS
19OverdoseFAERS: 5US FAERS
20Transaminases increasedFAERS: 5US FAERS
21jaundiceFAERS: 5US FAERS
22Apparent deathFAERS: 4US FAERS
23ArthralgiaFAERS: 4US FAERS
24Blood cholesterol increasedFAERS: 4US FAERS
25Diabetes MellitusFAERS: 4US FAERS
26FatigueFAERS: 4US FAERS
27VomitingFAERS: 4US FAERS
28AbasiaFAERS: 3US FAERS
29Abdominal discomfortFAERS: 3US FAERS
30ArthritisFAERS: 3US FAERS
31Blood sodium decreasedFAERS: 3US FAERS
32Blood urea increasedFAERS: 3US FAERS
33Bone painFAERS: 3US FAERS
34Carpal Tunnel SyndromeFAERS: 3US FAERS
35DizzinessFAERS: 3US FAERS
36FolliculitisFAERS: 3US FAERS
37Hepatitis B antibody abnormalFAERS: 3US FAERS
38Myoglobin blood increasedFAERS: 3US FAERS
39SyncopeFAERS: 3US FAERS
40Accidental exposureFAERS: 2US FAERS
41AcholiaFAERS: 2US FAERS
42Albumin globulin ratio decreasedFAERS: 2US FAERS
43AmnesiaFAERS: 2US FAERS
44Amyotrophic Lateral SclerosisFAERS: 2US FAERS
45AnhedoniaFAERS: 2US FAERS
46Apolipoprotein A-I decreasedFAERS: 2US FAERS
47AppendicitisFAERS: 2US FAERS
48Atrioventricular BlockFAERS: 2US FAERS
49Back PainFAERS: 2US FAERS
50BedriddenFAERS: 2US FAERS
51Bilirubin conjugated increasedFAERS: 2US FAERS
52Blood albumin decreasedFAERS: 2US FAERS
53Blood creatine phosphokinase MB increasedFAERS: 2US FAERS
54Blood glucose increasedFAERS: 2US FAERS
55Blood iron increasedFAERS: 2US FAERS
56Blood phosphorus decreasedFAERS: 2US FAERS
57CholelithiasisFAERS: 2US FAERS
58CholestasisFAERS: 2US FAERS
59Chronic sinusitisFAERS: 2US FAERS
60Cystatin C increasedFAERS: 2US FAERS
61DiscomfortFAERS: 2US FAERS
62Drug toxicityFAERS: 2US FAERS
63Emphysematous bullaFAERS: 2US FAERS
64EosinophiliaFAERS: 2US FAERS
65ErythemaFAERS: 2US FAERS
66Feeling abnormalFAERS: 2US FAERS
67HeadacheFAERS: 2US FAERS
68HepatotoxicityFAERS: 2US FAERS
69HypotensionFAERS: 2US FAERS
70InfectionFAERS: 2US FAERS
71LeukopeniaFAERS: 2US FAERS
72Low density lipoprotein increasedFAERS: 2US FAERS
73Lupus-like syndromeFAERS: 2US FAERS
74Macular degenerationFAERS: 2US FAERS
75Musculoskeletal chest painFAERS: 2US FAERS
76Myocardial InfarctionFAERS: 2US FAERS
77Neck PainFAERS: 2US FAERS
78NegativismFAERS: 2US FAERS
79Ocular icterusFAERS: 2US FAERS
80PancreatitisFAERS: 2US FAERS
81PeriodontitisFAERS: 2US FAERS
82PolyneuropathyFAERS: 2US FAERS
83Pulmonary FibrosisFAERS: 2US FAERS
84Retinal infarctionFAERS: 2US FAERS
85Rotator cuff syndromeFAERS: 2US FAERS
86Suicide attemptFAERS: 2US FAERS
87Suture insertionFAERS: 2US FAERS
88Systemic Inflammatory Response SyndromeFAERS: 2US FAERS
89TenosynovitisFAERS: 2US FAERS
90ThrombocytopeniaFAERS: 2US FAERS
91Tooth LossFAERS: 2US FAERS
92Total bile acids increasedFAERS: 2US FAERS
93Umbilical herniaFAERS: 2US FAERS
94VertigoFAERS: 2US FAERS
95Walking aid userFAERS: 2US FAERS
96AcidosisFAERS: 1US FAERS
97Acute myocardial infarctionFAERS: 1US FAERS
98AnorexiaFAERS: 1US FAERS
99Antinuclear antibody increasedFAERS: 1US FAERS
100ArthropathyFAERS: 1US FAERS
101AsthmaFAERS: 1US FAERS
102Atrial FibrillationFAERS: 1US FAERS
103Blood glucose decreasedFAERS: 1US FAERS
104Blood potassium decreasedFAERS: 1US FAERS
105Blood potassium increasedFAERS: 1US FAERS
106Blood testosterone decreasedFAERS: 1US FAERS
107Blood triglycerides increasedFAERS: 1US FAERS
108Brain AbscessFAERS: 1US FAERS
109Breast CystFAERS: 1US FAERS
110BronchitisFAERS: 1US FAERS
111Carbohydrate antigen 19-9 increasedFAERS: 1US FAERS
112CataractFAERS: 1US FAERS
113ChokingFAERS: 1US FAERS
114ChorioretinitisFAERS: 1US FAERS
115Completed SuicideFAERS: 1US FAERS
116Creatinine renal clearance decreasedFAERS: 1US FAERS
117Deep Vein ThrombosisFAERS: 1US FAERS
118Drug dose omissionFAERS: 1US FAERS
119Duodenal UlcerFAERS: 1US FAERS
120DysuriaFAERS: 1US FAERS
121Electrocardiogram abnormalFAERS: 1US FAERS
122Erythema NodosumFAERS: 1US FAERS
123Facial ParesisFAERS: 1US FAERS
124FibromyalgiaFAERS: 1US FAERS
125GastritisFAERS: 1US FAERS
126General physical health deteriorationFAERS: 1US FAERS
127GlaucomaFAERS: 1US FAERS
128Guillain-Barre SyndromeFAERS: 1US FAERS
129Hepatitis B positiveFAERS: 1US FAERS
130HepatomegalyFAERS: 1US FAERS
131HypersensitivityFAERS: 1US FAERS
132HypokinesiaFAERS: 1US FAERS
133Idiopathic Pulmonary FibrosisFAERS: 1US FAERS
134Impaired gastric emptyingFAERS: 1US FAERS
135Incorrect dose administeredFAERS: 1US FAERS
136Intervertebral Disc DegenerationFAERS: 1US FAERS
137Limb operationFAERS: 1US FAERS
138LymphadenopathyFAERS: 1US FAERS
139Medication residueFAERS: 1US FAERS
140Middle insomniaFAERS: 1US FAERS
141Muscle CrampFAERS: 1US FAERS
142Muscular DystrophyFAERS: 1US FAERS
143Musculoskeletal stiffnessFAERS: 1US FAERS
144Myocardial necrosis marker increasedFAERS: 1US FAERS
145MyoglobinaemiaFAERS: 1US FAERS
146MyositisFAERS: 1US FAERS
147Nasal PolypsFAERS: 1US FAERS
148NeuropathyFAERS: 1US FAERS
149Ocular discomfortFAERS: 1US FAERS
150OsteochondrosisFAERS: 1US FAERS
151OsteolysisFAERS: 1US FAERS
152PainFAERS: 1US FAERS
153PallorFAERS: 1US FAERS
154PalpitationsFAERS: 1US FAERS
155ParotitisFAERS: 1US FAERS
156PneumoniaFAERS: 1US FAERS
157Post procedural complicationFAERS: 1US FAERS
158Protein urine presentFAERS: 1US FAERS
159Pulmonary EmbolismFAERS: 1US FAERS
160Respiratory FailureFAERS: 1US FAERS
161Retinal Vein OcclusionFAERS: 1US FAERS
162Shoulder PainFAERS: 1US FAERS
163Sinus headacheFAERS: 1US FAERS
164Skin lacerationFAERS: 1US FAERS
165Skin reactionFAERS: 1US FAERS
166ThirstFAERS: 1US FAERS
167ThrombosisFAERS: 1US FAERS
168Unevaluable eventFAERS: 1US FAERS
169Urinary RetentionFAERS: 1US FAERS
170Wrong technique in product usage processFAERS: 1US FAERS
171muscle injuryFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.